Celgene Expands Cancer Portfolio
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 12 (Table of Contents)
Published: 15 Dec-2009
DOI: 10.3833/pdr.v2009.i12.1286 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Celgene Corporation announced a definitive merger agreement to acquire the privately-held biopharmaceutical company, Gloucester Pharmaceuticals, for a total of US$640 M to build its cancer drugs portfolio...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS